Trial NCT03712930

View at ClinicalTrials.gov 
Org. Study IDs: BGB-290-202
Secondary IDs: 2018-002587-28

Last trial update was posted on 2021-11-17

MeSH Interventions

Pamiparib

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Homologous Recombination Deficiency (HRD) Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Stopping Reasons

Sponsor's decision to revisit the development approach for prostate cancer.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID